Hyderabad: The phase-2 clinical trial of the indigenously developed Covaxin began on Tuesday in Nagpur.
Bharat Biotech, the Hyderabad-based firm behind it, is testing the vaccine at Nagpur’s Gillurkar Hospital. In the first phase, 55 volunteers had undergone the test.
None of the volunteers reported any complication after the first dose. The vaccine trial will continue with a gap of 28 days, 42 days, 104 days and 194 days. The blood samples will be checked for growth in antibodies after each dose.
Bhubaneswar: Ollywood singer Asima Panda, who was stopped performing midway by the police at a…
Singapore/Bhubaneswar: Chief Minister Mohan Charan Majhi, who is on a four-day visit to Singapore, on…
Cuttack: The toll in mango kernel incident in Odisha’s Kandhamal rose to three as another…
New Delhi: On a day when Congress demanded the resignations of Amit Shah and Manipur Chief…
Bhubaneswar: In the wake of a controversy triggered by reports about a boy being projected…
New Delhi: A contestant appearing to mock actor Deepika Padukone's battle with depression on Samay…
Cuttack: Senior BJP leader and former minister Samir Dey breathed his last on Monday while…
Mahayuti vs Maha Vikas Aghadi - it's an electoral Mahabharat in Maharashtra, albeit a lot…